Pfizer Wins Lipitor Patent Challenge
In a significant victory for Pfizer, Inc., the U.S. Patent and Trademark Office is planning to issue a re-examination certificate for a contested patent for its best-selling drug, the $9.2 billion...To view the full article, register now.
Already a subscriber? Click here to view full article